BioRestorative Therapies (BRTX) Assets (2010 - 2025)

BioRestorative Therapies (BRTX) has reported Assets for 16 consecutive years, with $4.1 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Assets fell 66.78% year-over-year to $4.1 million; the trailing twelve-month figure through Dec 2025 stood at $4.1 million (down 66.78% YoY), and the FY2025 full-year result was $4.1 million, down 66.78% from the prior year.
• Assets fell to $4.1 million in Q4 2025 per BRTX's latest filing, from $5.6 million in the prior quarter.
• Across five years, Assets topped out at $22.5 million in Q4 2021 and bottomed at $2.2 million in Q3 2021.
• Historically, Assets has averaged $12.5 million across 5 years, with a median of $13.6 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Assets jumped 723.9% in 2022, then plunged 66.78% in 2025.
• Over 5 years, Assets stood at $22.5 million in 2021, then retreated by 26.81% to $16.4 million in 2022, then slipped by 23.26% to $12.6 million in 2023, then decreased by 2.63% to $12.3 million in 2024, then slumped by 66.78% to $4.1 million in 2025.
• According to Business Quant data, Assets over the past three periods registered $4.1 million, $5.6 million, and $8.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.